These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9462614)

  • 21. Microvascular angina in systemic hypertension: diagnosis and treatment with enalapril.
    Iriarte MM; Caso R; Murga N; López de Argumedo M; Sagastagoitia D
    Am J Cardiol; 1995 Nov; 76(13):31D-34D. PubMed ID: 7495215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of renin-angiotensin system blockers on left ventricular hypertrophy and biochemical markers of collagen balance in patients with hypertensive hypertrophy].
    Ovchinnikov AG; Serbul VM; Ageev FT
    Ter Arkh; 2009; 81(5):64-71. PubMed ID: 19537590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
    Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
    Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of mibefradil and enalapril on 24-hour blood pressure control and left ventricular mass in patients with mild to moderate hypertension: double-blind, randomized trial.
    Martina B; Lorz W; Frach B; Bart T; Battegay EJ
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):647-51. PubMed ID: 10218737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Losartan versus enalapril in the reduction of left ventricular hypertrophy secondary to systemic arterial hypertension].
    Uribe Flores JD; Hernández Jácome M; Guevara Dondé J; Segura X
    Arch Cardiol Mex; 2004; 74(3):192-9. PubMed ID: 15559871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical and hemodynamic efficacy of telmisartan and enalapril in the treatment of arterial hypertension in patients with type 2 diabetes mellitus].
    Tatarchenko IP; Pozdniakova NV; Mordovina AG; Morozova OI; Zaĭtseva AV
    Ter Arkh; 2009; 81(12):11-5. PubMed ID: 20481040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Wachtell K; Dahlöf B; Rokkedal J; Papademetriou V; Nieminen MS; Smith G; Gerdts E; Boman K; Bella JN; Devereux RB
    Am Heart J; 2002 Dec; 144(6):1057-64. PubMed ID: 12486431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertensive retinal vascular changes: relationship to left ventricular hypertrophy and arteriolar changes before and after treatment.
    Dahlöf B; Stenkula S; Hansson L
    Blood Press; 1992 May; 1(1):35-44. PubMed ID: 1345141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH; Myers MG; Joyner CD; Toal CB
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
    Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K
    Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regression of left ventricular hypertrophy and improvement of its diastolic function in patients with arterial hypertension under influence of antihypertensive therapy].
    Borzova NV; Gorbachenkov AA
    Kardiologiia; 2008; 48(6):44-50. PubMed ID: 18729836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of hypertensive patients with left ventricular hypertrophy].
    Ambrosioni E
    Presse Med; 2002 Oct; 31 Spec No 2():S13-6. PubMed ID: 12355999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Step-down of enalapril treatment for arterial hypertension.
    González-Juanatey JR; Reino AP; García-Acuña JM; González-Juanatey C; Valdes L; Cabezas-Cerrato J
    Hypertension; 1999 Dec; 34(6):1287-92. PubMed ID: 10601132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression of left ventricular hypertrophy in children with antihypertensive therapy.
    Ramaswamy P; Lytrivi ID; Paul C; Golden M; Kupferman JC
    Pediatr Nephrol; 2007 Jan; 22(1):141-3. PubMed ID: 16955278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Open trial using ACE inhibitor. Left ventricular hypertrophy diminishes].
    Arend U; Albrecht S; Meisel E; Schmidt J
    MMW Fortschr Med; 2002 Nov; 144(48):51. PubMed ID: 12532545
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril.
    Ciulla MM; Paliotti R; Esposito A; Cuspidi C; Muiesan ML; Rosei EA; Magrini F; Zanchetti A
    J Hypertens; 2009 Mar; 27(3):626-32. PubMed ID: 19262230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of enalapril on left ventricular hypertrophy and left ventricular function in patients with hypertension].
    Kakinoki S; Takechi S; Hashimoto M; Sakuma I; Nomura A; Kitabatake A; Yasuda H
    Kokyu To Junkan; 1993 Dec; 41(12):1185-9. PubMed ID: 8284542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of valsartan on left ventricular myocardial functions in hypertensive patients with left ventricular hypertrophy.
    Kucukler N; Kurt IH; Topaloglu C; Gurbuz S; Yalcin F
    J Cardiovasc Med (Hagerstown); 2012 Mar; 13(3):181-6. PubMed ID: 22306782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.